ArticleJournal of medicinal chemistry2023
Dual Piperidine-Based Histamine H
Abstract read
In one paragraph
Article in Journal of medicinal chemistry, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.
0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
9 citing papers in PubMed.
- Synthesis and Biological Activity of Novel Aromatic Aminopropyl Lactams in Two Cancer Cell Models.ChemMedChem · 2026Article
- Integrated GC-MS and UHPLC-HRMS/MS profiling of bioactive compounds from Streptomyces sp. BPA-6 isolated from bees-collected pollen.Metabolomics : Official journal of the Metabolomic Society · 2026Article
- Targeting Sigma-1 and Sigma-2 Receptors in Neuropathic Pain: Pharmacology, Ligand Development, and Translational Progress.Brain sciences · 2026Review
- Modulation of Tau Protein Neurotoxic Hallmarks by Novel σChemMedChem · 2026Article
- Development and validation of a method for quantitative determination of the genotoxic impurity diethyl sulfate in pitolisant hydrochlorideRSC advances · 2025Article
- Recent Advances in the Development of Sigma Receptor (Radio)Ligands and Their Application in Tumors.ACS pharmacology & translational science · 2025Review
- AR71, Histamine HInternational journal of molecular sciences · 2024Article
- Design and Synthesis of Multi-Functional Ligands through Hantzsch Reaction: Targeting CaPharmaceutics · 2024Article
- Novel object recognition test as an alternative approach to assessing the pharmacological profile of sigma-1 receptor ligands.Pharmacological reports : PR · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
25 authors.
Katarzyna SzczepańskaDepartment of Technology and Biotechnology of Drugs, Faculty of Pharmacy, Jagiellonian University Medical College, Medyczna 9, 30-688 Kraków, Poland.ORCID 0000-0002-6110-9400
Tadeusz KarczDepartment of Technology and Biotechnology of Drugs, Faculty of Pharmacy, Jagiellonian University Medical College, Medyczna 9, 30-688 Kraków, Poland.
Maria DichiaraDepartment of Drug and Health Sciences, University of Catania, V.le A. Doria, 95125 Catania, Italy.ORCID 0000-0001-6380-7176
Szczepan MogilskiDepartment of Pharmacodynamics, Faculty of Pharmacy, Jagiellonian University Medical College, Medyczna 9, 30-688 Kraków, Poland.
Justyna Kalinowska-TłuścikDepartment of Crystal Chemistry and Crystal Physics, Faculty of Chemistry, Jagiellonian University, Gronostajowa 2, 30-387 Kraków, Poland.
Bogusław PilarskiCerko Sp. z o.o. Sp.k, Al. Zwycięstwa 96/98, 81-451 Gdynia, Poland.
Arkadiusz LeniakCelon Pharma S.A., R&D Centre, Marymoncka 15, 05-152 Kazuń Nowy, Poland.
Wojciech PietruśDepartment of Medicinal Chemistry, Maj Institute of Pharmacology, Polish Academy of Sciences, Smętna 12, 31-343 Kraków, Poland.ORCID 0000-0002-8563-7929
Sabina PodlewskaDepartment of Medicinal Chemistry, Maj Institute of Pharmacology, Polish Academy of Sciences, Smętna 12, 31-343 Kraków, Poland.ORCID 0000-0002-2891-5603
Katarzyna Popiołek-BarczykDepartment of Neurochemistry, Maj Institute of Pharmacology, Polish Academy of Sciences, Smętna 12, 31-343 Kraków, Poland.
Laura J HumphrysInstitute of Pharmacy, Faculty of Chemistry and Pharmacy, University of Regensburg, Universitätsstraße 31, D-93053 Regensburg, Germany.ORCID 0000-0003-4019-5538
M Carmen Ruiz-CanteroDepartment of Pharmacology and Neurosciences Institute (Biomedical Research Center), University of Granada, and Biosanitary Research Institute ibs. Granada, Avenida de la Investigación 11, 18016 Granada, Spain.ORCID 0000-0001-6968-0946
David Reiner-LinkInstitute of Pharmaceutical and Medicinal Chemistry, Heinrich Heine University Düsseldorf, Universitaetsstr. 1, 40225 Düsseldorf, Germany.
Luisa LeitzbachInstitute of Pharmaceutical and Medicinal Chemistry, Heinrich Heine University Düsseldorf, Universitaetsstr. 1, 40225 Düsseldorf, Germany.
Dorota ŁażewskaDepartment of Technology and Biotechnology of Drugs, Faculty of Pharmacy, Jagiellonian University Medical College, Medyczna 9, 30-688 Kraków, Poland.ORCID 0000-0001-8454-4440
Steffen PockesInstitute of Pharmacy, Faculty of Chemistry and Pharmacy, University of Regensburg, Universitätsstraße 31, D-93053 Regensburg, Germany.ORCID 0000-0002-2211-9868
Michał GórkaCelon Pharma S.A., R&D Centre, Marymoncka 15, 05-152 Kazuń Nowy, Poland.
Adam ZmysłowskiCelon Pharma S.A., R&D Centre, Marymoncka 15, 05-152 Kazuń Nowy, Poland.
Thierry CalmelsBioprojet-Biotech, 4rue du Chesnay Beauregard, 35762 Saint-Gregoire Cedex, France.
Enrique J CobosDepartment of Pharmacology and Neurosciences Institute (Biomedical Research Center), University of Granada, and Biosanitary Research Institute ibs. Granada, Avenida de la Investigación 11, 18016 Granada, Spain.
Agostino MarrazzoDepartment of Drug and Health Sciences, University of Catania, V.le A. Doria, 95125 Catania, Italy.ORCID 0000-0002-8728-8857
Holger StarkInstitute of Pharmaceutical and Medicinal Chemistry, Heinrich Heine University Düsseldorf, Universitaetsstr. 1, 40225 Düsseldorf, Germany.ORCID 0000-0003-3336-1710
Andrzej J BojarskiDepartment of Medicinal Chemistry, Maj Institute of Pharmacology, Polish Academy of Sciences, Smętna 12, 31-343 Kraków, Poland.ORCID 0000-0003-1417-6333
Emanuele AmataDepartment of Drug and Health Sciences, University of Catania, V.le A. Doria, 95125 Catania, Italy.ORCID 0000-0002-4750-3479
Katarzyna Kieć-KononowiczDepartment of Technology and Biotechnology of Drugs, Faculty of Pharmacy, Jagiellonian University Medical College, Medyczna 9, 30-688 Kraków, Poland.
Funding
No grant is acknowledged in the PubMed record.
Abstract
In search of new dual-acting histamine H
Indexed as
NeuralgiaReceptors, Histamine H3Receptors, sigmaHistamineHumansLigandsNociceptionPiperazinePiperidinesSigma-1 ReceptorStructure-Activity RelationshipHistamineLigandsPiperazinePiperidinesReceptors, Histamine H3Receptors, sigmaSigma-1 Receptor
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.